FDA
Silver Spring, MD
Ann Meeker-O’Connell is the Director of FDA’s Office of Clinical Policy in the Office of the Chief Medical Officer. In this role, she leads an organization that develops cross-cutting policy related to clinical development and research ethics. Ms. Meeker-O’Connell has more than 20 years of experience in medical product development, spanning trial design and operations, quality assurance, and risk management. She earned an MS in Pharmacology and was an NIH Integrated Toxicology Fellow at Duke University.
C10 - Updates to the Declaration of Helsinki
Monday, November 18, 2024
3:30 PM – 4:45 PM PT